WHO Grades II and III Glioma

The classification of lower-grade gliomas has been greatly altered since the 2016 World Health Organization (WHO) introduced molecular diagnostics as part of their recommendations. Clinical trials that dictate treatment approaches, however, are based on histological classification. This chapter addresses the standard guidelines for contouring and planning for treatment of lower-grade gliomas, as well as clinical pearls for imaging.